[c09aa8]: / clusters / ordered9kclusters / clust_1416.txt

Download this file

64 lines (63 with data), 4.8 kB

 1
 2
 3
 4
 5
 6
 7
 8
 9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
Woman who is pregnant or lactating or has a positive pregnancy test at screening. If a woman has a positive pregnancy test, further evaluation may be conducted to rule out ongoing pregnancy to allow the patient to be eligible
Female subjects who have positive serum pregnancy test taken within 14 days of initiation of study treatment.
Female patients who are nursing or have a positive pregnancy test during screening are not eligible
A WOCBP who has a positive urine pregnancy test within 24 hours before the first dose of study treatment.
Has a positive pregnancy test within 72 hours before the first dose of study therapy
Positive serum pregnancy test
A positive pregnancy test will exclude patients from the study in addition to excluding them from receiving standard therapy
Women with a positive pregnancy test
DONOR: Females with a positive pregnancy test
A WOCBP who has a positive serum pregnancy test within 72 hours prior to enrollment on study
WOCBP who has a positive urine pregnancy test within 72 hours before the first dose of study treatment
Women with a positive pregnancy test at enrollment or prior to administration of study medication.
Women with a positive pregnancy test
Women with a positive pregnancy test or lactating.
Participants with borderline pregnancy tests at Screening must have a serum pregnancy test ? 3 days later to document continued lack of a positive result.
Women with a positive pregnancy test on enrollment or prior to investigational product administration
Positive pregnancy test for women of childbearing age
Women with a positive pregnancy test on enrollment or prior to investigational product administration
Women who are not post-menopausal and have a positive urine or serum pregnancy test or refuse to take a pregnancy test
Women with a positive pregnancy test.
Women with a positive pregnancy test
Positive pregnancy test in a female
Positive serum pregnancy test
Positive serum pregnancy test
Positive pregnancy test for women of childbearing age
Women who are not post-menopausal and have a positive urine or serum pregnancy test or refuse to take a pregnancy test
220 Females with a positive pregnancy test.
WOCBP who has a positive urine pregnancy test within 72 hours before the first dose of study treatment
Women with a positive pregnancy test on enrollment or prior to investigational product administration
DONOR: Females with a positive pregnancy test
Women who are not post-menopausal and have a positive urine or serum pregnancy test or refuse to take a pregnancy test
Women with a positive pregnancy test on enrollment or prior to investigational product administration
Known pregnancy, nursing women or positive pregnancy test
Women with a positive pregnancy test at enrollment or prior to administration of study medication
Positive pregnancy test in a female
Positive pregnancy test
Women with a positive pregnancy test on enrollment or prior to investigational product administration
A WOCBP who has a positive urine pregnancy test within 24 hours before the first dose of study treatment
Pregnant (positive pregnancy test)
Women with a positive pregnancy test
Women with a positive pregnancy test on enrollment or before investigational product administration
Women with a positive pregnancy test
Positive pregnancy test.
Woman who is pregnant or lactating or has a positive pregnancy test at screening. If a woman has a positive pregnancy test, further evaluation may be conducted to rule out ongoing pregnancy to allow the patient to be eligible.
Pregnant (positive pregnancy test) or lactating
Inadequate organ functions, positive pregnancy test.
Female subjects who have positive serum pregnancy test taken within 14 days of study treatment
Women with a positive pregnancy test on enrollment or prior to investigational product administration
Women with a positive pregnancy test at study entry.
Positive pregnancy test on day of surgery
Positive pregnancy test or breastfeeding of patient or donor (women of childbearing age only)
Positive pregnancy test
Positive pregnancy test (women of childbearing age only)
Positive pregnancy test or nursing (women of childbearing age only)
Women who are not post-menopausal and have a positive urine or serum pregnancy test or refuse to take a pregnancy test
Positive pregnancy test
Pregnancy, or positive pregnancy test
Currently known to be pregnant; (Note that urine pregnancy tests will be performed prior to the DXA and pQCT studies; positive pregnancy test at that time would preclude participation; a positive pregnancy test will be immediately reported to the patient’s primary oncology provider)
Positive serum pregnancy test in WOCBP
Positive pregnancy test
Positive serum pregnancy test for females
Positive Hemoglobin-Solubility (e.g., SickleDex™ or equivalent) test.
Pregnancy, or positive pregnancy test